Onconova Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
NEWTOWN, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be participating in-person in the Ladenburg Thalmann 2022 Healthcare Conference, which is taking place at the Sofitel Hotel in New York, NY.
Related news for (ONTX)
- Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
- Onconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder
- Onconova Therapeutics Presents Preclinical Data Characterizing Rigosertib’s Mechanisms of Action at the AACR Targeting RAS Conference
- Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series
- Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference